Your browser doesn't support javascript.
loading
[Prognostic Impact of 1q21 Amplification in Newly Diagnosed Multiple Myeloma Patients Receiving Bortezomib-Based First-Line Treatment].
Deng, Ping; Zhou, Yu-Lan; Wei, Yan-Lin; Li, Pu; Li, Fei.
Afiliação
  • Deng P; Department of Science and Education, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
  • Zhou YL; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
  • Wei YL; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
  • Li P; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
  • Li F; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China. E-mail: yx021021@sina.com.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 25(6): 1696-1701, 2017 Dec.
Article em Zh | MEDLINE | ID: mdl-29262900
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Aberrações Cromossômicas / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: Zh Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Aberrações Cromossômicas / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: Zh Ano de publicação: 2017 Tipo de documento: Article